Most cost discussions about Mounjaro focus on the per-month price at a given dose. That is part of the picture but not all of it. The true annual cost includes the titration months (cheaper than maintenance), consultations, and the medical aid picture, which differs dramatically by indication.
This page is an editorial cost analysis for someone planning a year on Mounjaro.
The Per-Dose Pricing
Approximate SA pharmacy pricing as of mid 2026, varying by retailer and dispensing fee:
| Dose | Approximate monthly cost |
|---|---|
| 2.5 mg (starting) | ~R3,400 to R3,600 |
| 5 mg | ~R3,800 to R4,000 |
| 7.5 mg | ~R4,200 to R4,400 |
| 10 mg | ~R4,600 to R4,800 |
| 12.5 mg | ~R4,800 to R5,200 |
| 15 mg (maximum) | ~R5,000 to R5,500+ |
Always confirm current pricing with your pharmacy before commitment. SEP updates and dispensing fees vary.
A 12 Month Budget Walkthrough
Tracking a typical year of treatment, assuming standard titration through to 15 mg:
| Months | Dose | Approximate monthly cost | Cumulative |
|---|---|---|---|
| Month 1 | 2.5 mg | R3,500 | R3,500 |
| Month 2 | 5 mg | R3,900 | R7,400 |
| Month 3 | 7.5 mg | R4,300 | R11,700 |
| Month 4 | 10 mg | R4,700 | R16,400 |
| Month 5 | 12.5 mg | R5,000 | R21,400 |
| Months 6 to 12 | 15 mg | R5,200 x 7 | R57,800 |
| Year 1 total (medication only): | ~R57,800 | ||
This is the upper end. Many people stay at 10 mg or 7.5 mg as maintenance, which lowers the annual cost meaningfully.
Year at 10 mg maintenance (not escalating to 15 mg)
Roughly R45,000 to R48,000 per year.
Year at 7.5 mg maintenance
Roughly R40,000 to R43,000 per year.
Add: consultation costs
Online Doctor SA consultations are R250 each. Initial plus periodic follow ups across the year add roughly R1,000 to R1,500.
The Medical Aid Picture
For type 2 diabetes
Diabetes is on the PMB Chronic Disease List. Medical aids must cover diabetes treatment, although they have discretion on which medications are on their chronic formulary. Many SA schemes have Mounjaro on chronic formulary for diabetes, with criteria varying.
The practical effect: for type 2 diabetes patients, medical aid cover for Mounjaro is often available, sometimes with prior authorisation. The out of pocket cost can drop substantially.
For weight management
Obesity is not on the PMB Chronic Disease List. Medical aids are not legally required to cover weight management medications. Cover varies considerably.
Typical patterns across major SA schemes:
- Discovery Health. Cover from medical savings account (MSA) on most plans, subject to scheme rules
- Bonitas, Momentum, Fedhealth, GEMS. Variable, usually from medical savings rather than chronic benefit
- Hospital plans. Generally no cover for outpatient weight management medications
Discuss Your Cost Picture
A consultation can help you understand likely maintenance dose, which affects ongoing cost.
Start ConsultationCost Comparison To Alternatives
| Medication | Typical monthly cost (SA, mid 2026) |
|---|---|
| Mounjaro (Tirzepatide) | R3,400 to R5,500 |
| Wegovy (Semaglutide) | R1,873 to R3,746 |
| Saxenda (Liraglutide) | R2,000 to R3,500 |
| Orlistat (Xenical generic) | R400 to R800 |
| Ozempic (Semaglutide for diabetes) | ~R2,800 |
Mounjaro is currently the most expensive option in the SA weight management space. Whether the additional cost is justified depends on the individual case and the consulting doctor's recommendation. More on the Wegovy comparison.
How To Reduce Cost
Confirm pharmacy pricing
Pricing varies between major retailers (Clicks, Dis-Chem, Alpha Pharm), independent pharmacies, and online dispensing pharmacies. Compare before settling on a regular supplier.
Stay at the lowest effective dose
Higher doses cost more. Many people respond well at 7.5 mg or 10 mg. There is no benefit to going to 15 mg if a lower dose produces the right outcome.
Medical aid optimisation
If your scheme covers Mounjaro from chronic benefit (most likely for diabetes indication), the out of pocket cost drops substantially. For weight management, MSA cover is the common route.
Tax claim
Medical expenses, including out of pocket prescription medications, may be partially claimable depending on your tax situation. Keep your invoices.
What Not To Do
Future Pricing
Three factors will shape Mounjaro pricing in SA over the coming years:
- Continued competition from Wegovy. Novo Nordisk has already reduced Wegovy prices twice in 2026. This puts downward pressure on Mounjaro pricing.
- The generic question. Tirzepatide is patent protected in SA into the 2030s. Generic competition will not arrive soon. Semaglutide generics may arrive by 2027, which could indirectly affect Mounjaro pricing.
- Medical aid policy evolution. If obesity is eventually added to the PMB Chronic Disease List, the cover picture would shift substantially. This is a slow but possible trend.
Frequently Asked
Roughly R3,400 to over R5,000 per month depending on dose. Starting doses at the lower end, maximum dose at the upper end. Pricing varies by pharmacy.
For type 2 diabetes, often yes (diabetes is on the PMB Chronic Disease List). For weight management, cover is variable because obesity is not on the CDL. Check with your scheme directly.
Wegovy became cheaper after Novo Nordisk's March 2026 price reductions, particularly during the early titration months. Mounjaro is currently more expensive at most dose stages.
Not soon. Patent analysis suggests tirzepatide generics in SA are unlikely before the 2030s. Generic semaglutide may arrive by 2027.